Neurocrine Biosciences (NASDAQ:NBIX) PT Raised to $128.00
Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price raised by Royal Bank of Canada from $123.00 to $128.00 in a report released on Wednesday morning, Benzinga reports. They currently have a sector perform rating on the stock. A number of other equities analysts have also recently commented on the company. Raymond James boosted […]
More Stories
703 Shares in CrowdStrike Holdings, Inc. (NASDAQ:CRWD) Acquired by OLD National Bancorp IN
OLD National Bancorp IN purchased a new position in CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) during the 1st quarter,...
Barry Sanders Net Worth 2025: NFL Icon’s Financial Playbook
Renowned as one of the best running backs in NFL history, Barry Sanders has not only made an impact in...
Artificial Intelligence Revolutionizes Slot Game Development and Player Experience
Slot gaming has seen major changes over the past years, and one of the key factors that brought about this...
OLD National Bancorp IN Has $378,000 Holdings in General Motors (NYSE:GM)
OLD National Bancorp IN increased its stake in shares of General Motors (NYSE:GM – Free Report) (TSE:GMM.U) by 18.4% in...
Veralto Co. (NYSE:VLTO) Shares Acquired by Park Avenue Securities LLC
Park Avenue Securities LLC lifted its position in shares of Veralto Co. (NYSE:VLTO – Free Report) by 11.5% during the...
OLD National Bancorp IN Buys 799 Shares of Manulife Financial Co. (NYSE:MFC)
OLD National Bancorp IN boosted its position in shares of Manulife Financial Co. (NYSE:MFC – Free Report) (TSE:MFC) by 8.8%...